• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
The risk factors for brain metastases in patients with non-small cell lung cancer.非小细胞肺癌患者发生脑转移的危险因素。
Ann Transl Med. 2018 Nov;6(Suppl 1):S66. doi: 10.21037/atm.2018.10.27.
2
Surgical treatment of primary lung cancer with synchronous brain metastases.原发性肺癌伴同步脑转移的外科治疗
J Thorac Cardiovasc Surg. 2001 Sep;122(3):548-53. doi: 10.1067/mtc.2001.116201.
3
Incidence of Brain Metastases on Follow-up F-FDG PET/CT Scans of Non-Small Cell Lung Cancer Patients: Should We Include the Brain?非小细胞肺癌患者随访F-FDG PET/CT扫描中脑转移的发生率：我们应该将脑部纳入检查范围吗？
J Nucl Med Technol. 2017 Sep;45(3):193-197. doi: 10.2967/jnmt.117.194571. Epub 2017 Jul 13.
4
The predictive value and potential mechanisms of miRNA-328 and miRNA-378 for brain metastases in operable and advanced non-small-cell lung cancer.miRNA-328和miRNA-378对可手术及晚期非小细胞肺癌脑转移的预测价值及潜在机制
Jpn J Clin Oncol. 2015 May;45(5):464-73. doi: 10.1093/jjco/hyv009. Epub 2015 Feb 2.
5
Stage III non-small cell lung cancer and metachronous brain metastases.III期非小细胞肺癌和异时性脑转移瘤。
J Thorac Cardiovasc Surg. 2002 Jul;124(1):113-22. doi: 10.1067/mtc.2002.121678.
6
Risk factors for brain metastases in surgically staged IIIA non-small cell lung cancer patients treated with surgery, radiotherapy and chemotherapy.接受手术、放疗和化疗的手术分期为IIIA期非小细胞肺癌患者发生脑转移的危险因素。
Vojnosanit Pregl. 2011 Aug;68(8):643-9. doi: 10.2298/vsp1108643p.
7
[The role of surgical treatment of primary non-small cell lung cancer with synchronous brain metastases].
Khirurgiia (Sofiia). 2010(6):5-7.
8
Optimal management of brain metastases in oncogenic-driven non-small cell lung cancer (NSCLC).驱动基因阳性非小细胞肺癌脑转移的最佳处理。
Lung Cancer. 2019 Mar;129:63-71. doi: 10.1016/j.lungcan.2018.12.009. Epub 2018 Dec 10.
9
Treatment of brain metastases from lung cancer: chemotherapy.肺癌脑转移的治疗：化疗。
Lung Cancer. 2004 Aug;45 Suppl 2:S253-7. doi: 10.1016/j.lungcan.2004.07.967.
10
Radiation-enhancing effect of sodium glycididazole in patients suffering from non-small cell lung cancer with multiple brain metastases: A randomized, placebo-controlled study.甘氨双唑钠对非小细胞肺癌多发脑转移患者的放疗增敏作用：一项随机、安慰剂对照研究。
Cancer Radiother. 2016 May;20(3):187-92. doi: 10.1016/j.canrad.2016.02.008. Epub 2016 Apr 1.

引用本文的文献

1
Application of prediction model based on CT radiomics in prognosis of patients with non-small cell lung cancer.基于CT影像组学的预测模型在非小细胞肺癌患者预后中的应用
BMC Cancer. 2025 Aug 6;25(1):1273. doi: 10.1186/s12885-025-14544-8.
2
Assessing survival in non-small cell lung cancer brain metastases after stereotactic radiosurgery: before and after the start of the targetable mutation era.评估立体定向放射外科治疗后非小细胞肺癌脑转移瘤的生存情况：在可靶向突变时代开始前后。
J Neurooncol. 2024 Sep;169(3):671-681. doi: 10.1007/s11060-024-04749-5. Epub 2024 Jul 1.
3
Survival Predictive Nomograms for Non-Surgical Brain Metastases Patients From Non-Small Cell Lung Cancer Receiving Radiotherapy: A Population-Based Study.非小细胞肺癌放疗后脑转移患者的生存预测列线图：基于人群的研究。
Cancer Control. 2024 Jan-Dec;31:10732748241255212. doi: 10.1177/10732748241255212.
4
Clinical Management of Patients with Non-Small Cell Lung Cancer, Brain Metastases, and Actionable Genomic Alterations: A Systematic Literature Review.非小细胞肺癌脑转移及可操作基因组改变患者的临床处理：系统文献回顾。
Adv Ther. 2024 May;41(5):1815-1842. doi: 10.1007/s12325-024-02799-9. Epub 2024 Mar 21.
5
Interim survival analysis of the randomized phase III GEMSTONE-302 trial: sugemalimab or placebo plus chemotherapy as first-line treatment for metastatic NSCLC.GEMSTONE-302 随机 III 期试验的中期生存分析： sugemalimab 或安慰剂联合化疗作为转移性 NSCLC 的一线治疗。
Nat Cancer. 2023 Jun;4(6):860-871. doi: 10.1038/s43018-023-00578-z. Epub 2023 Jun 15.
6
Brain Metastasis Incidence and Patterns of Presentation After Definitive Treatment of Locally Advanced Non-Small Cell Lung Cancer: A Potential Argument for Brain Magnetic Resonance Imaging Surveillance.局部晚期非小细胞肺癌根治性治疗后脑转移的发生率及表现模式：脑磁共振成像监测的潜在依据
Adv Radiat Oncol. 2022 Oct 23;8(3):101058. doi: 10.1016/j.adro.2022.101058. eCollection 2023 May-Jun.
7
Brain parenchymal and leptomeningeal metastasis in non-small cell lung cancer.非小细胞肺癌的脑实质和软脑膜转移。
Sci Rep. 2022 Dec 26;12(1):22372. doi: 10.1038/s41598-022-26131-z.
8
Adult brain tumors in Sub-Saharan Africa: A scoping review.撒哈拉以南非洲地区的成人大脑肿瘤：一项范围界定综述。
Neuro Oncol. 2022 Oct 3;24(10):1799-1806. doi: 10.1093/neuonc/noac098.
9
Tumor Immune Microenvironment and Immunotherapy in Brain Metastasis From Non-Small Cell Lung Cancer.脑转移非小细胞肺癌的肿瘤免疫微环境与免疫治疗
Front Immunol. 2022 Feb 17;13:829451. doi: 10.3389/fimmu.2022.829451. eCollection 2022.
10
The construction and validation of the model for predicting the incidence and prognosis of brain metastasis in lung cancer patients.预测肺癌患者脑转移发生率和预后模型的构建与验证
Transl Cancer Res. 2021 Jan;10(1):22-37. doi: 10.21037/tcr-20-2745.

本文引用的文献

1
The Incidence of Brain Metastases in Stage IV ROS1-Rearranged Non-Small Cell Lung Cancer and Rate of Central Nervous System Progression on Crizotinib.ROS1 重排 IV 期非小细胞肺癌脑转移的发生率和克唑替尼治疗下中枢神经系统进展率。
J Thorac Oncol. 2018 Nov;13(11):1717-1726. doi: 10.1016/j.jtho.2018.07.001. Epub 2018 Jul 5.
2
Non-small-cell Lung Cancer With Brain Metastasis at Presentation.初诊时伴脑转移的非小细胞肺癌。
Clin Lung Cancer. 2018 Jul;19(4):e373-e379. doi: 10.1016/j.cllc.2018.01.007. Epub 2018 Mar 9.
3
Early stage non-small cell lung cancer patients need brain imaging regardless of symptoms.早期非小细胞肺癌患者无论有无症状均需进行脑部成像。
Int J Clin Oncol. 2018 Aug;23(4):641-646. doi: 10.1007/s10147-018-1254-y. Epub 2018 Feb 26.
4
Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.非小细胞肺癌临床实践指南（2017 年第 5 版），NCCN 肿瘤学临床实践指南
J Natl Compr Canc Netw. 2017 Apr;15(4):504-535. doi: 10.6004/jnccn.2017.0050.
5
Incidence of Brain Metastasis at the Initial Diagnosis of Lung Squamous Cell Carcinoma on the Basis of Stage, Excluding Brain Metastasis.不包括脑转移的情况下，基于分期的肺鳞癌初始诊断时的脑转移发生率。
J Thorac Oncol. 2016 Mar;11(3):426-31. doi: 10.1016/j.jtho.2015.11.007. Epub 2015 Dec 30.
6
Brain Metastases at Presentation in Patients With Non-Small Cell Lung Cancer.非小细胞肺癌患者初诊时的脑转移
Am J Clin Oncol. 2018 Jan;41(1):36-40. doi: 10.1097/COC.0000000000000230.
7
A nomogram to predict brain metastasis as the first relapse in curatively resected non-small cell lung cancer patients.用于预测根治性切除的非小细胞肺癌患者首次复发为脑转移的列线图。
Lung Cancer. 2015 May;88(2):201-7. doi: 10.1016/j.lungcan.2015.02.006. Epub 2015 Feb 16.
8
Incidence of brain metastasis at initial presentation of lung cancer.肺癌初次就诊时脑转移的发生率。
Neuro Oncol. 2015 Jan;17(1):122-8. doi: 10.1093/neuonc/nou099. Epub 2014 Jun 2.
9
EGFR mutation and brain metastasis in pulmonary adenocarcinomas.肺腺癌中的 EGFR 突变与脑转移。
J Thorac Oncol. 2014 Feb;9(2):195-9. doi: 10.1097/JTO.0000000000000069.
10
Comparison of clinical characteristics between patients with ALK-positive and EGFR-positive lung adenocarcinoma.ALK阳性与EGFR阳性肺腺癌患者临床特征的比较。
Respir Med. 2014 Feb;108(2):388-94. doi: 10.1016/j.rmed.2013.11.020. Epub 2013 Dec 10.

The risk factors for brain metastases in patients with non-small cell lung cancer.

作者信息

Lim Jun Hyeok, Um Sang-Won

机构信息

Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

出版信息

Ann Transl Med. 2018 Nov;6(Suppl 1):S66. doi: 10.21037/atm.2018.10.27.

DOI:10.21037/atm.2018.10.27
PMID:30613641
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6291587/
Abstract
摘要